JENNIFER MOONEY: Open Payments
NPI 1952498891 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$341 in 13 payments from 7 companies in 2025. Trend: 2023 $707 · 2024 $402 · 2025 $341
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $148 |
| Lilly USA, LLC | 4 | $72 |
| Aimmune Therapeutics, Inc. | 3 | $49 |
| Astellas Pharma US Inc | 1 | $24 |
| IBSA Pharma Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Wegovy, KISUNLA, ZENPEP, Veozah, Tirosint, MOUNJARO, NURTEC ODT, XIFAXAN.
Industry payments across CO — which companies pay providers there.
